Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GALA: GnRH Agonist for Luteal Phase Support in IVF
NCT02262416Phase 3Unknown
- Sponsor
- Queensland Fertility Group
- Start
- Jan 2015
- Primary completion
- Jan 2016
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of leuprolide in infertility (2 arms), sponsored by Queensland Fertility Group. Primary endpoint: Live Birth at 1 year. Status: unknown.
02
Drugs
leuprolide
03
Conditions
infertility
Beyond the preview
Go deeper on NCT02262416.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02262416.